Acute Myeloid Leukemia Cells Harboring MLL Fusion Genes or with the Acute Promyelocytic Leukemia Phenotype Are Sensitive to the Bcl-2-selective Inhibitor ABT-199

Ítems similars

• Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
  per: Zhao, Jianyun, et al.
  Publicat: (2016)
• Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
  per: Luedtke, Daniel A, et al.
  Publicat: (2017)
• Synergistic anti-leukemic interactions between ABT-199 and panobinostat in acute myeloid leukemia ex vivo
  per: Schwartz, Jonathan, et al.
  Publicat: (2016)
• MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
  per: Benito, Juliana M., et al.
  Publicat: (2015)
• Selective BCL-2 Inhibition by ABT-199 Causes On Target Cell Death in Acute Myeloid Leukemia
  per: Pan, Rongqing, et al.
  Publicat: (2013)